Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. C. Morlacchi, S. Aliberti, S. Seghezzi, V. Giunta, F. Giuliani, S. Galbiati, B. Dallari, A. Gramegna, M. Di Pasquale, G. Spoletini, A. M. Brambilla, J. Bordon, F. Blasi (Milano, Monza, Italy; Washington, United States Of America). Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP). Eur Respir J 2011; 38: Suppl. 55, 2478

Member's Comments

No comment yet.

Related content which might interest you: Community-aquired pneumonia: systemic and local inflammatory response in treatment failure Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS) development in community-acquired pneumonia (CAP) Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Effects of empirical antibacterial therapy on the degree of systemic inflammatory response in patients with severe community-acquired pneumonia (SCAP) Source: Eur Respir J 2003; 22: Suppl. 45, 2s Year: 2003 Down-regulation of pro-inflammatory response genes of circulating leukocytes in ICU patients with severe pneumonia meeting criteria of systemic inflammatory response syndrome (SIRS) Source: Eur Respir J 2003; 22: Suppl. 45, 543s Year: 2003 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Difference of immune response in patients with severe acute pneumonia and lung abscesses Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004 Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)? Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011